This annual conference updated patent litigators and attorneys on the ongoing European and EU initiatives in the field of patent law. The focus was on emerging technologies used as medical therapies or treatment methods on the human being, including genome engineering, biomedical applications of human stem cells and nucleic acid-related inventions. The invitation was a result of the topics of the conference being at the core of the research conducted by Professor Timo Minssen, CeBIL Centre and the broader CeBIL project.